secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001193125-22-211269
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen appoints Michael V. Drake to Board of Directors effective August 3, 2022
------------------------------------------------------------------------------

- Dr. Drake is president of the University of California, with medical and academic leadership background.
- Board now has 13 directors, 12 of whom are independent.
- He will serve on the Corporate Responsibility & Compliance and Governance & Nominating Committees.
- Standard director compensation includes pro-rated annual retainer of $105,000, committee retainer of $12,500, and RSU grant valued at $210,000.
- No arrangements or transactions exist between Dr. Drake and Amgen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/0001193125-22-211269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/d386700d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-211269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer